Success Metrics

Clinical Success Rate
88.9%

Based on 24 completed trials

Completion Rate
89%(24/27)
Active Trials
0(0%)
Results Posted
46%(11 trials)
Terminated
3(10%)

Phase Distribution

Ph phase_3
7
23%
Ph not_applicable
2
7%
Ph phase_1
1
3%
Ph phase_4
11
37%
Ph phase_2
3
10%

Phase Distribution

1

Early Stage

3

Mid Stage

18

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
1(4.2%)
Phase 2Efficacy & side effects
3(12.5%)
Phase 3Large-scale testing
7(29.2%)
Phase 4Post-market surveillance
11(45.8%)
N/ANon-phased studies
2(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

24 of 27 finished

Non-Completion Rate

11.1%

3 ended early

Currently Active

0

trials recruiting

Total Trials

30

all time

Status Distribution
Completed(24)
Terminated(3)
Other(3)

Detailed Status

Completed24
Terminated3
unknown3

Development Timeline

Analytics

Development Status

Total Trials
30
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.2%)
Phase 23 (12.5%)
Phase 37 (29.2%)
Phase 411 (45.8%)
N/A2 (8.3%)

Trials by Status

terminated310%
unknown310%
completed2480%

Recent Activity

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT05815719Phase 4

Continuous Double Ovarian Stimulation.

Completed
NCT00702338

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)

Completed
NCT00702234

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)

Completed
NCT00598208Phase 2

A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

Completed
NCT00696800Phase 3

A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

Completed
NCT01146418Phase 3

Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)

Completed
NCT00696878Phase 3

Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)

Completed
NCT00697255Phase 2

A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

Terminated
NCT01709331Phase 3

A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)

Completed
NCT03019575Phase 3

Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)

Completed
NCT04695483Phase 4

Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial

Completed
NCT03197077Phase 3

Optimisation of Follicular Recruitment in IVM Cycles

Completed
NCT04482751

The Relationship Between Serum AMH Dynamics and Early or Normal Ovarian Response to Corifollitropin Alfa

Unknown
NCT02402192Phase 4

Type of Gonadotropin and Embryo Kinetics of Development

Terminated
NCT00702624

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)

Completed
NCT00702546

Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)

Completed
NCT01408615

A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)

Completed
NCT01319695Phase 1

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

Completed
NCT03208972Phase 4

Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG

Completed
NCT04416607Not Applicable

Corifollitropin Alpha and Ovarian Response

Completed

Drug Details

Intervention Type
DRUG
Total Trials
30